The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-β-D-xylopyranosyl-(1-6)-β-D-glucopyranoside in the human intestinal cell line Caco-2

Pharmaceutical Research

Volumn 23, Issue 8, 2006, Pages 1721-1728

  Tian, Xiaojuan ^a   Yang, Xiaoda ^a   Wang, Kui ^a   Yang, Xiuwei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Caco 2 cells; Flavonoid; Isorhamnetin 3 O rutinoside; Morin; Transport

Indexed keywords

ADENOSINE TRIPHOSPHATE; APIGENIN; DIOSMETIN 7 O BETA DEXTRO XYLOPYRANOSYL(1-6) BETA DEXTRO GLUCOPYRANOSIDE; FLAVONOID; GLUCOPYRANOSIDE; GLYCOPROTEIN P INHIBITOR; GLYCOSIDE; IODOACETAMIDE; ISORHAMNETIN; ISORHAMNETIN 3 O RUTINOSIDE; MORIN; PROBENECID; UNCLASSIFIED DRUG; VERAPAMIL; VERLUKAST;

ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANTIOXIDANTS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISACCHARIDES; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; INTESTINES; IODOACETAMIDE; PROBENECID; PROPIONATES; QUERCETIN; QUINOLINES; VERAPAMIL;

EID: 33746867995     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9030-5     Document Type: Article

References (49)

1. N. C. Cook and S. Samman. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. Nutr. Biochem. 7:66-76 (1996).
2. Y. Hanasaki, S. Ogawa, and S. Fukui. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic. Biol. Med. 16:845-850 (1994).
3. E. Middleton, C. Kandaswami, and J. B. Harborne (eds.), The Flavonoids; Advances in Research since 1986, Chapman & Hall, London, 1994.
4. W. C. Hope, A. F. Welton, C. Fielder-Nagy, C. Batula-Gernardo, and J. W. Coffey. In vitro inhibition of the biosynthesis of slow reacting substances of anaphylaxis (SRS_A) and lipoxygenase activity of quercetin. Biochem. Pharmacol. 32:367-371 (1983).
5. J. Duarte, F. P. Vizcaino, P. Utrilla, J. Jimenez, J. Tamargo, and A. Zarzuelo. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure activity relationships. Biochem. Pharmacol. 24:857-862 (1993).
6. A. K. Ratty and N. P. Das. Effects of flavonoids on nonenzymic lipid peroxidation: structure activity relationship. Biochem. Med. Metabol. Biol. 39:69-79 (1988).
7. R. Sslvayre, A. Negre, A. Affany, M. Lenoble, L. Douste-Blazy. Plant Flavonoids in Biology and Medicine II, Alan R. Liss, New York, New York, 1988.
8. R. J. Gryglewski, R. Korbut, J. Robak, and J. Swies. On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 36:317-322 (1987).
9. B. Bourdillat, D. Delautier, J. Labat, J. Benveniste, P. Potier, and C. Brink. Mechanism of action of Hispidulin, a natural flavone, on human platelets. In Plant Flavonoids in Biology and Medicine II. Biochemical, Cellular and Medicinal Properties. Alan R. Liss, New York, New York, 1988, pp. 211-214.
10. A. Beretz and J. Cazenave. The effect of flavonoids on blood-vessel wall interactions. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medicinal Properties. Alan R. Liss, New York, New York, 1988, pp. 187-200.
11. A. Beretz, R. Anton, and J. Cazenave. The effect of flavonoids on cyclic nucleotide phosphodiesterase. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships. Alan R. Liss, New York, New York, 1986, pp. 281-296.
12. S. H. Tzeng, W.-C. Ko, F.-N. Ko, and C.-M. Teng. Inhibition of platelet aggregation by some flavonoids. Thromb. Res. 64:91-100 (1991).
13. J. Robak, R. Korbut, F. Shridi, J. Swies, and H. R. zadkowska-Bodalska. On the mechanism of antiaggregatory effect of myricetin. Pol. J. Pharmacol. Pharm. 40:337-340 (1988).
14. J. Torel, J. Cillard, and P. Cillard. Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry 25:383-385 (1986).
15. S. Budavari, M. J. O'Neil, A. Smith, and P. E. Heckelman. The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals11Merck & Co., USA, 1989.
16. W. F. Hodnick, E. B. Milosavljevic, J. H. Nelson, and R. S. Pardini. Electrochemistry of flavonoids: relationships between redox potentials, inhibition of mitochondrial respiration and production of oxygen radicals by flavonoids. Biochem. Pharmacol. 37:2607-2611 (1988).
17. B. Pignol, A. Etienne, A. Crastes de Paulet, C. Deby, J. M. Mencia-Huerta, and P. Braquet. Biochemical, Cellular and Medicinal Properties, Alan R. Liss, New York, New York, 1988.
18. C. G. Fraga, V. S. Martino, G. E. Ferraro, J. D. Coussio, and A. Boveris. Flavonoids as antioxidants evaluated b in vivo and in situ liver chemiluminescence. Biochem. Pharmacol. 36:717-720 (1987).
19. L. Cavallini, A. Bindoli, and N. Siliprandi. Comparative evaluation of antiperoxidative action of silymarin and other flavonoids. Pharmacol. Res. Commun. 10:133-136 (1978).
20. I. B. Afanas'ev, A. I. Dorozhko, A. V. Brodskii, V. A. Kostyuk, and A. I. Potapovitch. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 38:1763-1769 (1989).
21. P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:880-885 (1991).
22. S. Yee. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharm. Res. 14:763-766 (1997).
23. L. Hou, B. Zhou, L. Yang, and Z. L. Liu. Inhibition of free radical initiated peroxidation of human erythrocyte ghosts by flavonols and their glycosides. Org. Biomol. Chem. 7:1419-1423 (2004).
24. D. G. Kang, M. K. Moon, E. J. Sohn, D. H. Lee, and H. S. Lee. Effects of morin on blood pressure and metabolic changes in fructose-induced hypertensive rats. Biol. Pharm. Bull. 27no. 11, 1779-1783 (2004).
25. T. Ahlenstiel, G. Burkhardt, H. Köhler, and M. K. Kuhlmann. Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation. Kidney Int. 63:554-566 (2003).
26. J. Dean, P. James, and H. Q. Musich. Inside alternative and complementary medicine: a molecular study of how a simple flavonoid protects DNA from oxidative damage. Biochem. Pharmacol. 67(no. 5):967-975 (2004).
27. J. Brown, J. O'prey, and P. R. Harrison. Ehanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways. Carcinogenesis 24(no. 2):171-177 (2003).
28. 4 and structurally related conjugates. J. Biol. Chem. 169:27807-27810 (1994).
29. G. Jedlitschky, I. Leier, and U. Buchholz. ATP-dependent transport of glutathine S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:4833-4836 (1994).
30. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1967-1972 (1981).
31. F. J. Sharom. The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160:161-175 (1997).
32. J. Hunter, M. A. Jepson, T. Tsuruo, N. L. Simmons, and B. H. Hirst. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetecs of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268:14991-14997 (1993).
33. U. K. Walle and T. Walle. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem. Pharmacol. 58:431-438 (1999).
34. H. Gutmann, G. Fricker, M. Török, S. Michael, C. Beglinger, and J. Drewe. Evidence for different ABC-transporters in caco-2 cells modulating drug uptake. Pharm. Res. 16:402-407 (1999).
35. T. Walle, R. A. Walgren, U. K. Walle, A. Galijatovic, and J. B. Vaidyanathan. Flavonoids in Health and Disease, Marcel Dekker, New York, New York, 2003.
36. T. Hirohashi, H. Suzuki, X. Y. Chu, I. Tamai, A. Tsuji, and Y. Sugiyama. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292:265-270 (2000).
37. V. D. Makhey, A. Guo, D. A. Norris, P. Hu, J. Yan, and P. J. Sinko. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm. Res. 15:1160-1167 (1998).
38. R. A. Walgren, K. J. Karnaky Jr., G. E. Lindenmayer, and T. Walle. Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Ther. 294:830-836 (2000).
39. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84:7735-7738 (1987).
40. H. Bartels, E. Korsiak, and H. Daniel. Transport activity of the MDR1-gene product in monolayers of Caco-2 cells. Z. Gastroenterol. 32:15-18 (1994).
41. K. I. Hosoya, K. J. Kim, and V. H. Lee. Age-dependent expression of P-glycoprotein gp 170 in Caco-2 cell monolayers. Pharm. Res. 13:885-890 (1996).
42. M. M. Gottesman and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427 (1993).
43. C. H. M. Versantvoort, R. C. A. Ondrewater, E. Duizer, H. H. M. Van de Sandt, A. J. Gilde, and J. P. Groter. Monolayers of IEC-18 Cells as an in vivo model for screening the passive transcellular and paracellular transport across the intestinal barrier: comparison of active an passive transport with the human colon carcinoma Caco-2 cell line. Environ. Toxicol. Phar. 11:335-344 (2002).
44. J. B. Vaidyanathan and T. Walle. Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line caco-2. Pharm. Res. 18:1420-1425 (2001).
45. U. K. Walle, A. Galijatovic, and T. Walle. Transport of genistein-7-glucoside by human intestinal Caco-2 cell: potential role for MRP2. Commun. Mol. Pathol. Pharmacol. 103:45-56 (1999).
46. J. König, A. T. Nies, Y. Cui, I. Leier, and D. Keppler. Biochim. Biophys. Acta 1461:377-394 (1999).
47. S. Z. Zhang and M. Morris. Effects of the flavonoids biochanin a, morin, phloretin, and silymarin on p-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther. 304(no. 3):1258-1267 (2003).
48. H. Nguyen, S. Zhang, and M. E. Morris. Effect of flavonoids on MRP1-mediated transport in panc-1 cells. J. Pharm. Sci. 92:250-257 (2003).
49. N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama. Impact of drug transporter studies on drug discovery and development. Pharmcol. Rev. 55:425-461 (2003).